Over the past few decades, viral and non-viral vectors are increasingly being used for the development of novel therapies. These vectors are helpful in achieving in-vivo delivery of gene to a targeted cell or tissue. Viral vectors such as adeno-associated virus, lentivirus, and retrovirus are some of the commonly used vectors utilized in several clinical and preclinical trials evaluating gene and cell therapy products as well as vaccines. For example, recombinant retroviruses are mostly used for the development of various gene therapies, targeting a number of genetic diseases, such as Marfan syndrome, hemochromatosis, Huntington’s disease, and sickle cell anemia. Retroviruses are mainly used to increase the expression of the genes and for easy chromosomal integration.

1. Product Definition 

2. Scope of the Work 

3. Research Methodology 

4. Global Viral Vector and Plasmid Manufacturing Market Overview 

5. Market Dynamics

6. Industry Insights 

7. Competitive Landscape 

8. Global Viral Vector and Plasmid Manufacturing Market (by Vector) 

9. Global Viral Vector and Plasmid Manufacturing Market (by Disease) 

10. Global Viral Vector and Plasmid Manufacturing Market (by Application) 

11. Global Viral Vector and Plasmid Manufacturing Market (by Region)

12. Company Profiles